Glucose-dependent insulinotropic polypeptide (GIP): development of DP IV-resistant analogues with therapeutic potential

Adv Exp Med Biol. 2003:524:293-301. doi: 10.1007/0-306-47920-6_35.

Authors

Simon A Hinke¹, Francis Lynn, Jan Ehses, Nathalie Pamir, Susanne Manhart, Kerstin Kühn-Wache, Fred Rosche, Hans-Ulrich Demuth, Raymond A Pederson, Christopher H S McIntosh

Affiliation

¹ Department of Physiology, University of British Columbia, Vancouver, Canada.

PMID: 12675251
DOI: 10.1007/0-306-47920-6_35

No abstract available

Publication types

Research Support, Non-U.S. Gov't

MeSH terms

Amino Acid Sequence
Animals
Blood Glucose / metabolism
Diabetes Mellitus, Experimental / blood
Diabetes Mellitus, Experimental / drug therapy
Dipeptidyl Peptidase 4 / metabolism*
Disease Models, Animal
Gastric Inhibitory Polypeptide / chemistry
Gastric Inhibitory Polypeptide / physiology*
Gastric Inhibitory Polypeptide / therapeutic use
Molecular Sequence Data
Peptide Fragments / chemistry
Peptide Fragments / metabolism
Peptide Fragments / therapeutic use
Protein Structure, Secondary
Rats

Substances

Blood Glucose
Peptide Fragments
Gastric Inhibitory Polypeptide
Dipeptidyl Peptidase 4